KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares OutstandingShares Outstanding
Ratios

TherapeuticsMD (TXMD) Shares Outstanding (2016 - 2026)

TherapeuticsMD filings provide 17 years of Shares Outstanding readings, the most recent being $11.6 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding changed 0.0% to $11.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $11.6 million, a 0.0% change, with the full-year FY2025 number at $11.6 million, changed 0.36% from a year prior.
  • Shares Outstanding hit $11.6 million in Q1 2026 for TherapeuticsMD, roughly flat from $11.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $11.6 million in Q1 2025 to a low of $8.7 million in Q1 2022.
  • Median Shares Outstanding over the past 5 years was $11.5 million (2023), compared with a mean of $10.8 million.
  • Biggest five-year swings in Shares Outstanding: grew 21.42% in 2023 and later changed 0.0% in 2024.
  • TherapeuticsMD's Shares Outstanding stood at $9.5 million in 2022, then increased by 21.42% to $11.5 million in 2023, then changed by 0.0% to $11.5 million in 2024, then increased by 0.36% to $11.6 million in 2025, then changed by 0.0% to $11.6 million in 2026.
  • The last three reported values for Shares Outstanding were $11.6 million (Q1 2026), $11.6 million (Q4 2025), and $11.6 million (Q3 2025) per Business Quant data.